Pre-Market Stock News (APR 19, 2007)
(AAPL) Apple’s iPhone is not being delayed according to AT&T (Cingular).(ALTH) Allos Therapeutics’s PDX Granted Orphan Medicinal Product Designation by the European Commission.(AME) Ametek $0.48 EPS vs $0.46e.(ARB) Arbitron $0.52 EPS vs $0.50e.(BAC) Bank of America $1.17 EPS vs $1.15e.(BAX)…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
(AAPL) Apple’s iPhone is not being delayed according to AT&T (Cingular).
(ALTH) Allos Therapeutics’s PDX Granted Orphan Medicinal Product Designation by the European Commission.
(AME) Ametek $0.48 EPS vs $0.46e.
(ARB) Arbitron $0.52 EPS vs $0.50e.
(BAC) Bank of America $1.17 EPS vs $1.15e.
(BAX) Baxter $0.61 EPS vs $0.55e.
(BBT) BB&T $0.81 EPS vs $0.77e.
(BOT) CBOT $1.29 EPS vs $1.16e.
(BWA) Borg Warner noted positively by Cramer for green investing.
(DGX) Quest Diagnostics $0.79 EPS vs $0.69e.
(DHI) $0.16 EPS vs $0.27e; $0.32 EPS was raw number.
(DHR) Danaher $0.78 EPS vs $0.77e.
(EBAY) eBay traded up 5% after beating earnings.
(EBS) Emergent Biosolutions announces that HHS and DoD issued notices of intent to procure up to a combined 22.75 mln doses of BioThrax.
(FCBP) First Community Bancorp $0.98 EPS vs $0.86e.
(GERN) Geron says Studies Confirm Proof-of-Principle for it’s Human Embryonic Stem Cell Derived Hepatocytes.
(GILD) Gilead traded up to new year highs in after-hours trading after beating earnings expectations.
(HSY) Hershey Foods $0.51 EPS vs $0.51e.
(HYGS) Hydrogenics signed multiple HyPM Fuel Cell orders.
(KVHI) KVH Industries $0.00 EPS vs $0.02e.
(LOGI) Logitech $0.29 EPS vs $0.30e.
(MER) Merrill Lynch $2.26 EPS vs $1.97e.
(MO) Altria $1.03 EPS vs $1.05e.
(MSFT) Microsoft in license pact with Samsung.
(MRK) Merck $0.84 EPS vs $0.84e; guides next Q $0.67 to $0.71 EPS vs $0.69e.
(NRMX) Neurochem says database for North American Phase III clinical trial for tramiprosate for treatment of Alzheimer’s disease has been locked up.
(ORB) Orbital Sciences $0.19 EPS vs $0.19e; guidance looks in-line to slightly above prior range.
(PTMK) Pathmark Stores $0.03 EPS vs -$0.03e.
(SPNC) Spectranetics $0.00 EPS vs -$0.01e.
(STJ) St. Jude Medical is selling $1B in convertible notes.
(TER) Teradyne trading up over 2% after earnings.
(UNH) UnitedHealth $0.74 EPS vs $0.71e.
(VICL) Vical is expanding testing of its Vaxfectin adjuvant to U.S. Navy malaria vaccine program.
(WYE) Wyeth $0.94 EPS vs $0.88e.
(YHOO) Yahoo!’s CEO Terry Semel noted as #1 CEO who needs to go by Cramer.
Jon C. Ogg
April 19, 2007
Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.
Contact [email protected] for any questions or corrections.